NeoVac is a clinical stage company creating revolutionary proprietary next-generation lipid nanoparticles to enable better mRNA vaccines and treatments for various diseases.

Our vision is to deliver first-in-class innovative remedies to allow more people around the world access to more transportable therapeutics, with broader capabilities and fewer side effects.We’re reshaping LNP delivery to precision targeting of organs and tissue which will unlock countless possibilities in the treatment of disease.

Our experienced team is uniquely positioned and poised for success in delivering the next generation of Lipid Nanoparticle (LNP) platform. Combining cutting-edge expertise in nanotechnology, precision medicine, and RNA-based drug delivery, alongside a proven track record in developing lipid nanoparticle technologies, the team is set to redefine the standards of therapeutic delivery.